| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/19/2009 | CN101507822A Reduction of dermal scarring |
| 08/19/2009 | CN101507821A Medicine for treating malignant cerebroma and breast cancer by combining gene and chemotherapy medicine and preparation method thereof |
| 08/19/2009 | CN100529063C Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 08/19/2009 | CN100529059C Oral recombined DNA vaccine for accelerating growth of animal, and application |
| 08/19/2009 | CN100528240C Preparation method and medicinal uses of Trichinella eelworm vaccine |
| 08/19/2009 | CN100528239C Method for killing specific tumour cell by recin |
| 08/19/2009 | CN100528238C Oral DNA combination for treating chronic infection of hepatitis B virus |
| 08/18/2009 | US7576197 SiRNA targeting KRAS |
| 08/18/2009 | US7576196 siRNA targeting transducin (beta)-like 3 (TBL3) |
| 08/18/2009 | US7576189 antibodies against such VEGFs, which may be used to inhibit their action, for example, to inhibit the growth of tumors, to treat diabetic retinopathy, rheumatoid arthritis and psoriasis |
| 08/18/2009 | US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption |
| 08/18/2009 | US7576065 Administering the neurotrophic factor and the inhibitor into the lateral ventricles or ventricular wall to induce neuronal production in the brain and spinal cord of the subject;. suppressing astrocyte generation; neurodegenerative diseases |
| 08/18/2009 | US7576052 Methods and compositions for modulating adipocyte function |
| 08/18/2009 | US7575924 Expression vector for use in the treatment and prevention of cancer |
| 08/18/2009 | US7575923 CD19xCD3 specific polypeptides and uses thereof |
| 08/18/2009 | US7575921 Used to reengineer damaged or diseased tissue, to augment existing tissue, to create new tissue, or to otherwise improve the condition of a patient who is suffering from disorder |
| 08/18/2009 | US7575919 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase |
| 08/18/2009 | US7575918 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 08/18/2009 | US7575857 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy |
| 08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 08/18/2009 | US7575743 Removing a portion of synovial membrane tissue from the animal; and filling the cartilage defect with the synovial membrane tissue. |
| 08/18/2009 | US7575741 Using interleukin-23 modulators to enhance wound healing |
| 08/18/2009 | US7575577 Devices and methods for the restoration of a spinal disc |
| 08/18/2009 | CA2413156C Expression vectors |
| 08/18/2009 | CA2392284C Medical device |
| 08/18/2009 | CA2288215C Use of immunomodulating agents |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/18/2009 | CA2223691C Tumor- or cell-specific herpes simplex virus replication |
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/13/2009 | WO2009100419A2 Method for prophylaxis and treatment of equine herpesvirus type 1 infections |
| 08/13/2009 | WO2009100351A2 Delivery of rnai constructs to oligodendrocytes |
| 08/13/2009 | WO2009100342A2 Disease markers and uses thereof |
| 08/13/2009 | WO2009100284A2 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
| 08/13/2009 | WO2009100254A2 Protein tyrosine phosphatase inhibitors |
| 08/13/2009 | WO2009100214A2 Induction of thyroid iodide-handling gene expression in human cancers |
| 08/13/2009 | WO2009100161A2 Epigenetic silencing of mir-342 in colorectal cancer |
| 08/13/2009 | WO2009100159A2 Methods of diagnosing and treating parp-mediated diseases |
| 08/13/2009 | WO2009100105A2 Inhibitors of oncogenic isoforms and uses thereof |
| 08/13/2009 | WO2009100024A2 METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTα-OSTβ) ACTIVITY AND TREATING ASSOCIATED CONDITIONS |
| 08/13/2009 | WO2009099991A2 Treatment of cancer |
| 08/13/2009 | WO2009099959A2 Tumor cell expression of neuropilin as a target for cancer therapy |
| 08/13/2009 | WO2009099942A2 Chemically modified oligonucleotides and uses thereof |
| 08/13/2009 | WO2009099507A2 Treating oncogenic ras driven cancers |
| 08/13/2009 | WO2009099326A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 08/13/2009 | WO2009098492A2 Modulation of adenoviral tropism |
| 08/13/2009 | WO2009097691A1 USE OF P27kip1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| 08/13/2009 | WO2009059201A3 Id2 as a target in colorectal carcinoma |
| 08/13/2009 | WO2009032308A8 Sam-ii riboswitch and uses thereof |
| 08/13/2009 | US20090205056 Method of screening for modulators of map3k11 in liver cancer cells |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090203896 Modulation of survivin expression |
| 08/13/2009 | US20090203895 siRNA targeting cyclin-dependent kinase 4 (CDK4) |
| 08/13/2009 | US20090203769 Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling |
| 08/13/2009 | US20090203768 Nucleic acid-containing complex |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203766 vWF aptamer formulations and methods for use |
| 08/13/2009 | US20090203765 Modulation of eif4e-bp2 expression |
| 08/13/2009 | US20090203638 Pharmaceutical compositions and methods for metabolic modulation |
| 08/13/2009 | US20090203144 Hiv-gag codon-optimised dna vaccines |
| 08/13/2009 | US20090203143 Trans-splicing mediated photodynamic therapy |
| 08/13/2009 | US20090203130 Mammalian stem cell of non-embryonic origin that is surface antigen negative for CD44, CD45, and HLA Class I and II; cardiovascular, nervous system diseases |
| 08/13/2009 | US20090203129 Multipotent adult stem cells and methods for isolation |
| 08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/13/2009 | US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/13/2009 | US20090203033 Test and model for alzheimer's disease |
| 08/13/2009 | US20090203024 Secreted protein called 36p6d5 characteristic of tumors |
| 08/13/2009 | US20090202623 Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent |
| 08/13/2009 | US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 08/13/2009 | US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | US20090202545 Melanoma biomarker and methods of uses |
| 08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
| 08/13/2009 | US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/13/2009 | US20090202493 Mir-150 for the treatment of blood disorders |
| 08/13/2009 | US20090202492 Adenovirus vaccine utilizing ikk as adjuvant |
| 08/13/2009 | US20090202491 Method for modulating, regulating and/or stabilizing angiogenesis |
| 08/13/2009 | US20090202489 Adenoviruses mutated in the va genes for cancer treatment |
| 08/13/2009 | US20090202488 Use Of The Foamy Virus Bet Protein For Inactivating APOBEC |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | CA2714972A1 Use of p27kip1 for the prevention and treatment of heart failure |
| 08/13/2009 | CA2714410A1 Disease markers and uses thereof |
| 08/13/2009 | CA2714378A1 Treatment of chronic pain with zinc finger proteins |
| 08/13/2009 | CA2714120A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 08/13/2009 | CA2713966A1 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
| 08/13/2009 | CA2713156A1 Methods of diagnosing and treating parp-mediated diseases |
| 08/12/2009 | EP2088193A1 Novel shuttle vector |
| 08/12/2009 | EP2087912A1 ENVIRONMENT-RESPONDING siRNA CARRIER USING DISULFIDE-BRIDGED POLYMERIC MICELLE |
| 08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 08/12/2009 | EP2086591A2 Efficient nuclear delivery of antisense oligonucleotides |
| 08/12/2009 | EP2086590A2 Modulation of t cell signaling threshold and t cell sensitivity to antigens |
| 08/12/2009 | EP2086589A2 Ultrasound microbubble mediated genes delivery system |
| 08/12/2009 | EP1687323A4 Methods and compositions for seamless cloning of nucleic acid molecules |
| 08/12/2009 | EP1559432B1 Hm1.24-utilizing cancer vaccines |
| 08/12/2009 | EP1465912B9 Chimeric tnf ligands |
| 08/12/2009 | EP1424895B1 Method for expression of small antiviral rna molecules within a cell |
| 08/12/2009 | EP1416048B1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 08/12/2009 | EP1401376A4 Colloidal metal compositions and methods |
| 08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 08/12/2009 | EP0898580B9 Methods and means for inhibition of cdk4 activity |